Comment
doi: 10.3324/haematol.2011.056077.
Empirical versus pre-emptive antifungal therapy for persistent febrile neutropenia
- PMID: 22210330
- PMCID: PMC3248937
- DOI: 10.3324/haematol.2011.056077
Item in Clipboard
Comment
Empirical versus pre-emptive antifungal therapy for persistent febrile neutropenia
Haematologica.
2012 Jan.
No abstract available
Comment on
-
The use and efficacy of empirical versus pre-emptive therapy in the management of fungal infections: the HEMA e-Chart Project.Haematologica. 2011 Sep;96(9):1366-70. doi: 10.3324/haematol.2011.042598. Epub 2011 May 12. Haematologica. 2011. PMID: 21565903 Free PMC article. Clinical Trial.
Similar articles
-
The use and efficacy of empirical versus pre-emptive therapy in the management of fungal infections: the HEMA e-Chart Project.Haematologica. 2011 Sep;96(9):1366-70. doi: 10.3324/haematol.2011.042598. Epub 2011 May 12. Haematologica. 2011. PMID: 21565903 Free PMC article. Clinical Trial.
-
The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Why empirical therapy?J Antimicrob Chemother. 2009 May;63 Suppl 1:i14-5. doi: 10.1093/jac/dkp075. J Antimicrob Chemother. 2009. PMID: 19372173 Review.
-
Meta-Analysis and Cost Comparison of Empirical versus Pre-Emptive Antifungal Strategies in Hematologic Malignancy Patients with High-Risk Febrile Neutropenia.PLoS One. 2015 Nov 10;10(11):e0140930. doi: 10.1371/journal.pone.0140930. eCollection 2015. PLoS One. 2015. PMID: 26554923 Free PMC article. Review.
-
Efficacy of pre-emptive versus empirical antifungal therapy in children with cancer and high-risk febrile neutropenia: a randomized clinical trial.J Antimicrob Chemother. 2018 Oct 1;73(10):2860-2866. doi: 10.1093/jac/dky244. J Antimicrob Chemother. 2018. PMID: 30010931 Clinical Trial.
-
Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial.Clin Infect Dis. 2009 Apr 15;48(8):1042-51. doi: 10.1086/597395. Clin Infect Dis. 2009. PMID: 19281327 Clinical Trial.
Cited by
-
Incidence density of invasive fungal infections during primary antifungal prophylaxis in newly diagnosed acute myeloid leukemia patients in a tertiary cancer center, 2009 to 2011.Antimicrob Agents Chemother. 2014;58(2):865-73. doi: 10.1128/AAC.01525-13. Epub 2013 Nov 25. Antimicrob Agents Chemother. 2014. PMID: 24277033 Free PMC article.
-
Recommendations for the Treatment of Invasive Fungal Infections in Hematological Malignancies: A Critical Review of Evidence and Turkish Expert Opinion (TEO-1).Turk J Haematol. 2014 Jun;31(2):111-20. doi: 10.4274/tjh.2014.0103. Epub 2014 Jun 10. Turk J Haematol. 2014. PMID: 25035667 Free PMC article. Review.
References
-
- Cordonnier C, Pautas C, Maury S, Vekhoff A, Farhat H, Suarez F, et al. Empirical versus Preemptive Antifungal Therapy for High Risk, Febrile, Neutropenic Patients: A Randomized, Controlled Trial. Clin Infect Dis. 2009;48(8):1042–51. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
